Zhuzhou Yuancheng Hezhong Technology Development Co., Ltd.
Inquire Now
Pharmaceutical Raw Materials >

Moxifloxacin Hydrochloride Cas:186826-86-8

Detailed Selling Lead Description
Brand: zzyc
Model: 186826-86-8
Min. Order: 10g
English Synonyms: AVALOX; ACTRIA; PROFLOX; MOXIFLOXACIN HCL
CAS Number: 186826-86-8
Molecular Formula: C21H25ClFN3O4
Molecular Weight: 437.89
Fluoroquinolones antibiotics
Moxifloxacin hydrochloride is a fluoroquinolone antibiotic drug developed by Bayer Pharmaceuticals of Germany. Its mechanism of action and in vitro antibacterial spectrum are similar to those of other fluoroquinolones, but its antibacterial activity against gram-positive bacteria and anaerobes Trovafloxacin is similar and superior to some older breeds. Compared with other fluoroquinolones, gram-positive bacteria resistant to this product have little or very slow resistance, and cross-links with other fluoroquinolones have been found in gram-negative bacteria and enterococci. Resistant bacteria. However, this product is effective against at least Staphylococcus aureus isolates grlA, grlB, gyrA or gyrB. This product can inhibit ciprofloxacin resistant Staphylococcus aureus from 0.5 to 2 mg/L. Ciprofloxacin, Ofloxacin, Levofloxacin, Sparfloxacin, Moxifloxacin.
Moxifloxacin hydrochloride can be used to treat socially acquired pneumonia caused by Staphylococcus aureus, influenza bacillus, pneumococcus, Moraxella catarrhalis, and Klebsiella pneumoniae, acute exacerbation of chronic bronchitis, and acute sinusitis.
Contact Us